Search > Plantar Fibroma
My employer runs this trial

Topical Cannabidiol for Plantar Fasciitis

AM
SH
Overseen ByShea Herlihy, MS
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: University of Florida
Must not be taking: Opioids, NSAIDs, Topical analgesics, others
Disqualifiers: Pregnancy, Breastfeeding, Allergy, others
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

This prospective, double-blinded, placebo-controlled study evaluates the efficacy of a 6000 mg transdermal CBD cream in adults with plantar fasciitis. Fifty participants will apply either CBD or placebo once daily for one month.

Are You a Good Fit for This Trial?

This trial is for adults diagnosed with plantar fasciitis or plantar fibroma. Participants must be able to apply a topical cream daily and meet other basic health requirements set by the study.

Inclusion Criteria

I have had heel pain from plantar fasciitis for at least four weeks.
I have been diagnosed with plantar fasciitis by a healthcare provider.
I am between 18 and 85 years old.
See 2 more

Exclusion Criteria

I do not have open wounds, infections, or skin problems on my heel or midfoot.
History of allergy or sensitivity to cannabinoids, excipients, or topical creams used in the study
I have had recent treatments like steroid injections or surgery for my condition.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants apply either CBD or placebo cream once daily for one month

4 weeks
Daily application

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • transdermal CBD cream (Tolcylen®)

Trial Overview

The study tests whether a CBD cream (Tolcylen) can quickly and effectively relieve foot pain from plantar fasciitis compared to a placebo. Participants are randomly assigned to use either the CBD cream or an inactive cream once daily for one month, without knowing which they receive.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Participants who receive a transdermal cannabidiol creamExperimental Treatment1 Intervention
Group II: Participants who receive a matched placeboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Florida

Lead Sponsor

Trials
1,428
Recruited
987,000+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.